|
The involvement of communities and clinical research sites in the developing world is extensive and will continue to expand in the coming years. This is where much of the epidemic rages and where AIDS vaccine candidates can be most efficiently and appropriately tested. This reality places additional burdens and responsibilities on parts of the world already overwhelmed by basic social and health needs. In such settings, scientists working on cohort development and vaccine trials often confront critical needs not covered by their budgets. Some of these needs could be satisfied with less than $2,000.
The AVAC Fund functions as a small-scale "emergency fund" to assist needy clinical sites that require immediate help with purchases such as additional medical or lab supplies not covered by grants or contracts for vaccine research.
Contributions to the Fund are tax deductible and are managed separately from AVAC's operating funds.
All AIDS vaccine clinical trial sites in resource-limited countries or needy communities, regardless of sponsor, can apply for grants up to $2,000. A committee consisting of HIV vaccine investigators from around the world reviews proposals and makes recommendations to a special AVAC Fund Committee of the AVAC Board. For a description of recent grantees, please click here.
Please direct any questions and requests for application materials to fund@avac.org.
The AVAC Fund is a direct and tangible way to assist AIDS vaccine clinical trial sites in communities that are struggling with the devastation of AIDS and to reward their heroic efforts in the search for a vaccine. Contributions can be made online with a credit card online through our secure server or by sending a check to AVAC Fund, 101 West 23rd St. #2227, New York, NY 10011.
This website Copyright 2006 AIDS Vaccine Advocacy Coalition
Site Design: Canfield Design Studios, Inc.
|
|
|
